EBV-RELATED LYMPHOPROLIFERATIVE DISORDER
Clinical trials for EBV-RELATED LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new EBV-RELATED LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for EBV-RELATED LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to stop Virus-Linked cancers in organ transplant patients
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a vaccine called OSU-2131, designed to help the immune system fight Epstein-Barr virus (EBV). EBV can cause cancers in people who have weakened immune systems, such as those awaiting organ transplants. The study includes healthy volunteers and transpl…
Matched conditions: EBV-RELATED LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 04, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase trial tests a new type of immune cell therapy for patients with EBV-positive Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard treatments. The researchers add a gene called C7R to the patient's own T cells to help them survive longer …
Matched conditions: EBV-RELATED LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC